Vascular News and Research

RSS

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Sickle cell disease is a devastating hereditary condition that affects millions of people, particularly those in West and Central Africa as well as people of African descent in the United States, Europe and South America.

23 Oct 2012

Acetylsalicylic acid slows decline in brain capacity among the elderly

A daily dose of acetylsalicylic acid equivalent to a fourth of an aspirin may slow the decline in intellectual capacity among elderly individuals with high cardiovascular risk. This is shown in a study by Sahlgrenska Academy, University of Gothenburg, Sweden.

22 Oct 2012

Patients with PAH may suffer greater disease burden after IV PGI2 combination therapy

Patients with pulmonary arterial hypertension (PAH) receiving combination therapy with intravenous (IV) PGI2 may suffer from greater disease burden compared with those receiving monotherapy or combination therapy, excluding IV PGI2.

22 Oct 2012

VEGF produced by NPCs plays a strong role in influencing microglial behavior

The brain's key "breeder" cells, it turns out, do more than that. They secrete substances that boost the numbers and strength of critical brain-based immune cells believed to play a vital role in brain health. This finding adds a new dimension to our understanding of how resident stem cells and stem cell transplants may improve brain function.

22 Oct 2012

Bayer announces data from riociguat Phase III pulmonary arterial hypertension trial

Bayer HealthCare today announced data from the Phase III PATENT-1 pulmonary arterial hypertension (PAH) trial evaluating its investigational drug riociguat in both treatment-naive patients and those pre-treated with an endothelin receptor antagonist or an oral, inhaled or subcutaneous prostanoid.

22 Oct 2012

Damage of endothelial glycocalyx may lead to heart troubles in kidney failure patients

Individuals with kidney failure often develop heart problems, but it's not clear why. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN) provides evidence that their kidneys' inability to excrete waste products in the urine, which leads to build-up of these products in the blood, may damage the sugary lining of blood vessels and lead to heart troubles.

20 Oct 2012

Reprogrammed vascular endothelial cells from ACs shows promise against vascular disorders

A new approach for generating large numbers of circulatory system cells, known as vascular endothelial cells (VECs), from human amniotic-fluid-derived cells (ACs) is reported in a study published by Cell Press October 18th in the journal Cell. The strategy, which shows promise in mice, opens the door to establishing a vast inventory of VECs for promoting organ regeneration and treating diverse vascular disorders.

20 Oct 2012

FDA expands approved indication for Sapien Transcatheter Heart Valve

The U.S. Food and Drug Administration today expanded the approved indication for the Sapien Transcatheter Heart Valve (THV) to include patients with aortic valve stenosis who are eligible for surgery, but who are at high risk for serious surgical complications or death.

20 Oct 2012

Reprogrammed endothelial cells for treatment of vascular disorders

A research team at Weill Cornell Medical College has discovered a way to utilize diagnostic prenatal amniocentesis cells, reprogramming them into abundant and stable endothelial cells capable of regenerating damaged blood vessels and repairing injured organs.

19 Oct 2012

Shunting may not ward off poor hydrocephalus cognitive outcomes

Around half of patients with idiopathic normal-pressure hydrocephalus will develop dementia, despite responding to shunting, study findings suggest.

19 Oct 2012

Reduced copayment policy has benefits all round

Reducing patients’ copayments for statins and clopidogrel could increase their adherence without adding financial burden to the healthcare system, researchers say.

18 Oct 2012

Blood pressure management may slow cognitive decline in PD

Cognitive dysfunction in Parkinson's disease is linked to neurocirculatory abnormalities such as orthostatic and supine hypertension, suggesting early treatment of such abnormalities may slow cognitive decline, say researchers.

17 Oct 2012

Nonpsychiatric medical costs high in bipolar disorder patients

The use of nonpsychiatric healthcare services is greater and associated costs higher in bipolar disorder patients than in those without the mood disorder, results from a Taiwanese study show.

17 Oct 2012

High nurse workloads may affect postsurgical outcomes of older minorities

Older black patients are three times more likely than older white patients to suffer poorer outcomes after surgery, including death, when cared for by nurses with higher workloads, reports research from the University of Pennsylvania School of Nursing.

17 Oct 2012

Vascular News and Research

Sickle cell disease treatments: An interview with Dr Niihara, CEO of Emmaus Medical

Acetylsalicylic acid slows decline in brain capacity among the elderly

Patients with PAH may suffer greater disease burden after IV PGI2 combination therapy

VEGF produced by NPCs plays a strong role in influencing microglial behavior

Bayer announces data from riociguat Phase III pulmonary arterial hypertension trial

Damage of endothelial glycocalyx may lead to heart troubles in kidney failure patients

Reprogrammed vascular endothelial cells from ACs shows promise against vascular disorders

FDA expands approved indication for Sapien Transcatheter Heart Valve

Reprogrammed endothelial cells for treatment of vascular disorders

Shunting may not ward off poor hydrocephalus cognitive outcomes

Reduced copayment policy has benefits all round

Blood pressure management may slow cognitive decline in PD

Nonpsychiatric medical costs high in bipolar disorder patients

High nurse workloads may affect postsurgical outcomes of older minorities

Canadian Task Force on Preventive Health Care releases new diabetes screening guidelines

Experts blaze TRAIL for pulmonary arterial hypertension therapy

Preclinical study finds how fat tissue fuels cancer growth

Wise Foundation announces name change

Pioneering research paves way for new treatments for pulmonary arterial hypertension

Downregulated protein could be revascularization target in critical limb ischemia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News